ARCHIVES

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

This article is from The Cancer Letter archive.

Vol. 14 No. 33 | August 12, 1988

Download PDF Visit The Full Archive

Related Articles

Dietary Interventions Reduce Breast Cancer Risk In Trials

May 27, 2005

NCI-Approved Clinical Trials

July 25, 2003

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

March 16, 1979

Regions Outlined In CIS Proposal

May 31, 1991